Cognitive Enhancement and Prescription Stimulant Use
Summary
The concept of cognitive enhancement encompasses the use of pharmacological agents by healthy individuals to improve mental functions such as attention, memory, alertness and executive control. Prescription stimulants—principally methylphenidate, amphetamine salt combinations and modafinil—are increasingly employed outside clinical indications in academic, professional and high-stress environments. Users pursue sharper concentration during study or work periods, extended wakefulness and heightened resilience under pressure. Empirical evidence suggests only modest gains on complex cognitive tasks, with substantial inter-individual variability in response. Alongside debates on effectiveness, concerns centre on safety, potential for dependence, legal and ethical implications, and issues of fairness and coercion. Regulatory frameworks vary internationally, complicating access and control. As research expands to include neuropharmacology, behavioural outcomes and societal impact, the phenomenon has assumed global significance, prompting calls for informed policy, education and responsible clinical practice.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Cognitive Enhancement and Prescription Stimulant Use publication trend
The graph below shows the total number of articles in cognitive enhancement and prescription stimulant use across all publications each year (not limited to Nature Index journals).
Technical terms
Cognitive enhancer: A pharmacological or technological intervention intended to improve mental functions in individuals without diagnosed disorders.
Prescription stimulant: A medication authorised for medical conditions (e.g. ADHD) that increases central nervous system activity and is used off-label for enhancement.
Off-label use: The non-approved prescription of a licensed medication for purposes or populations not specified in its official authorisation.
Attention deficit hyperactivity disorder (ADHD): A neurodevelopmental condition characterised by inattention, hyperactivity and impulsivity, for which stimulants are commonly prescribed.
References
- Methylphenidate use and misuse among medical residents in Israel: a cross-sectional study. Human Resources for Health (2023).
- The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review. Brain Sciences (2021).
- Cognitive enhancement by drugs in health and disease. Trends in Cognitive Sciences (2010).
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.